Health ❯Healthcare ❯Regulatory Affairs ❯Drug Approval

European Medicines Agency

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU